Showing results (21-30 of 21) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 21 results.
Lancet (London, England)|June 11, 2017
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialH Miles Prince, Youn H Kim, Steven M Horwitz, et al.Pageof 3